SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel $INTC is trending as chatter swirls around a potential investment from Apple $AAPL as part of Intel's turnaround efforts, fueled by a recent Bloomberg report. Community members are speculating about the implications of Apple taking a stake and potential collaborations, while some express skepticism, recalling past struggles. The news arrives amid broader discussions of government support for US chip manufacturing and Intel's role in the AI landscape.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending due to a surge in investor interest, fueled by a recent Air Force contract and non-dilutive funding, which validates the company's quantum computing roadmap. The community is actively discussing the stock's potential, comparing it to other high-growth tech stocks and debating whether it's overvalued. Some traders are pointing to a potential short squeeze, while others highlight the long-term potential of quantum computing and the company's partnerships.

Lithium Americas Corp. engages in the development of the Thacker Pass project. It is focused on advancing Thacker Pass to production it is located in northern Nevada. The company was founded on January 23, 2023 and is headquartered in Vancouver, Canada.

Lithium Americas Corp (NewCo)

Lithium Americas Corp

Lithium Americas ($LAC) is trending due to reports of the Trump administration potentially taking an equity stake in the company linked to a $2.26 billion Energy Department loan, sparking significant community discussion around potential government backing and the future of lithium supply. The news has triggered a surge in the stock price as investors speculate on the implications for the company's Thacker Pass project and the broader lithium sector, with some comparing it to previous government investments in critical industries. Discussions also include potential dilution and off-take agreements.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure ($QURE) is trending following positive Phase I/II data for its Huntington's disease gene therapy, with analysts raising price targets and the community discussing its potential for accelerated FDA approval. Bullish sentiment is fueled by the statistically significant slowing of disease progression, while some traders are wary of a potential offering or pullback. The stock's high short interest is adding to the volatility as traders debate whether to short the stock or ride the momentum.

TNF Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

TNF Pharmaceuticals Inc.

TNF Pharmaceuticals (TNFA) is trending as traders discuss its recent strategic shift towards quantum computing and a name change to Q/C Technologies, sparking both excitement and skepticism. Bullish sentiment centers on the potential of their exclusive rights to light-speed laser processing for cryptocurrency applications, while bears cite concerns about dilution and the company's history. The community is actively debating whether this pivot justifies the stock's increased volatility and potential for a short squeeze.

Astera Labs, Inc. is a global semiconductor company, which engages in the provision of hardware and software solutions for AI and cloud infrastructure applications to solve data, memory, and networking bottlenecks. It operates through the following geographical segments: Taiwan, China, United States, and Other. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

ALAB is trending due to a significant sell-off, with community members citing potential Intel/Nvidia competition and overvaluation concerns as possible catalysts; some suspect market manipulation. Despite strong YTD growth fueled by PCIe demand and a recent positive earnings report, investors are debating its sustainability amid competition from major players like AVGO and MRVL. Discussions include whether the drop is a buying opportunity or a sign of further declines.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

VKTX is trending amid speculation about a potential buyout or partnership, especially with other companies in the weight loss space being acquired. Community members are actively discussing potential suitors and the value of Viking's pipeline, citing positive trial data and a manageable tolerability profile. Some traders are eyeing technical indicators, while others are focused on upcoming presentations and potential catalysts.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending amid debates about its valuation and future prospects, with discussions focusing on its lack of current revenue and potential for an offering. Community sentiment is divided, with some highlighting insider selling and regulatory hurdles, while others point to the company's potential role in powering AI data centers. The stock's significant gains over the past month have also spurred conversations around pullbacks and potential buying opportunities within the nuclear sector.

Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.

Immuneering Corp - Ordinary Shares Class A

IMRX is trending following news of a clinical supply agreement with Eli Lilly to evaluate atebimetinib in combination with olomorasib for non-small cell lung cancer, leading to a significant surge in the stock price. The community is discussing the potential of this collaboration and its implications for Immuneering's pipeline strategy, while analysts adjust their ratings with some setting buy ratings and price targets. Some investors are speculating whether Lilly may eventually acquire Immuneering.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as the community discusses its recent price movement and potential breakout above the $15-$16 resistance level, with some pointing to a shift in market sentiment. The groundbreaking of the Georgia plant is also generating buzz, although some express concerns about cash burn and production timelines. Overall, the conversation is focused on whether Rivian can maintain its upward momentum and capitalize on upcoming catalysts like the R2 launch.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Strive (ASST) announced on Monday that it will acquire Semler Scientific (SMLR) in an all-stock deal, valuing the company at a roughly 210% premium.&nbsp;<a href="http://stocktwits.com/symbol/SMLR">Semler Scientific’s stock</a> jumped more than 10% at market open, with retail sentiment on Stocktwits climbing to ‘extremely bullish’ from ‘bearish over the past day. Retail chatter also surged to ‘extremely high’ from ‘high’ levels.&nbsp;Meanwhile,&nbsp;<a href="http://stocktwits.com/symbol/ASST">Strive’s stock</a> slipped more than 4% at market open on Monday, with retail sentiment around the Vivek Ramaswamy-backed company falling to ‘bullish’ from ‘extremely bullish’ territory over the past day and retail chatter slowing down to ‘high’ from ‘extremely high’ levels. The transaction, which will exchange each Semler share for 21.05 Class A shares of Strive, implies a price of $90.52 per Semler share based on last Friday’s closing prices. Alongside the merger, Strive announced it had purchased 5,816 Bitcoin (BTC) for its corporate treasury at an average price of $116,047 per coin, totaling roughly $675 million.At the time of writing,&nbsp;<a href="http://stocktwits.com/symbol/BTC.X">Bitcoin’s price</a> had already fallen to $112,800 after a dip of 2.5% over the past day.&nbsp;This puts Semler’s new Bitcoin purchase at an unrealized loss of around 2.7%.&nbsp;The new purchase brings Strive’s total Bitcoin holdings to 5,886. Combined with Semler Scientific’s existing Bitcoin holdings, the merged company would control more than 10,900 Bitcoins, with additional cash reserves set aside to support future perpetual preferred offerings.The companies said the merger will allow them to explore monetizing Semler Scientific’s diagnostics business while establishing a new management team and broadening its focus on preventative diagnostics. Strive’s current management and board will remain in place once the merger is complete, with Semler Scientific Executive Chairman Eric Semler expected to join the board of the combined company.The combined company aims to become the fastest-growing corporate Bitcoin holder, employing a “preferred equity only” leverage model, which it said is designed to avoid debt maturity risks associated with leveraged crypto strategies. Strive also stated it will maintain sufficient cash reserves to support future perpetual preferred offerings, while continuing to pursue growth in both digital asset holdings and the diagnostics sector.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/eth-price-drop-leads-1-6-b-crypto-liquidation-doge-sol-ada-hit-hardest/chDQVwbR32P">ETH Price Drop Leads $1.6B Crypto Liquidation – DOGE, SOL, ADA Hit Hardest</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Strive To Merge With Semler Scientific, Boosts Bitcoin Holdings To Nearly 11,000 BTC

Strive announced it has acquired an additional 5,816 Bitcoin for its corporate treasury, bringing the merged entity’s total holdings, including Semler Scientific’s existing Bitcoin, to approximately 10,900 BTC.

Equity

Semler Scientific (SMLR) announced on Thursday that it has acquired 175 Bitcoin (BTC) for $20.8 million, utilizing proceeds from its ATM offering.<a href="https://stocktwits.com/symbol/SMLR">Semler’s stock</a> edged 0.46% higher in pre-market trade. However, retail sentiment around the shares on Stocktwits dipped lower within ‘bearish’ territory as compared to a day ago.&nbsp;According to a&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.semlerscientific.com/node/11071/html">filing</a> with the Securities and Exchange Commission (SEC), the average purchase price of its newly acquired 175 BTC&nbsp;was $119,230 per Bitcoin. The latest haul brings the company’s total Bitcoin holdings to 5,021 BTC, acquired at a total cost of $475.8 million and valued at around $595 million as per&nbsp;<a href="http://stocktwits.com/symbol/BTC.X">Bitcoin’s price</a> early Thursday morning.The apex cryptocurrency was trending 0.3% higher in pre-market hours at around $118,500. On Tuesday, Bitcoin hit a new record high, crossing $120,000. It is currently trading 3.5% below that level, according to CoinGecko&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.coingecko.com/en/coins/bitcoin">data.</a>Semler Scientific also updated investors on its BTC Yield key performance indicator (KPI), reporting a 31.3% year-to-date return through July 23.&nbsp;The healthcare technology company pivoted to adopting Bitcoin as its primary treasury reserve asset in May 2024. It&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.semlerscientific.com/news-releases/news-release-details/semler-scientificr-appoints-joe-burnett-director-bitcoin">plans</a> to expand its Bitcoin holdings to 10,000 by the end of the year – more than double its current holdings. It aims to reach 42,000 BTC by the end of 2026 and 105,000 by the end of 2027.Semler has said it intends to use a mix of equity, debt, and operational cash flow for its Bitcoin accumulation plan.&nbsp;Semler’s stock has fallen more than 28% this year so far, but gained 15% over the past 12 months. Meanwhile, Bitcoin’s price has gained 26% this year and nearly 80% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/bitcoin-flat-while-ethereum-xrp-lead-950-million-crypto-liquidation-wave/ch8yMZyR5H5">Bitcoin Flat While Ethereum, XRP Lead $950 Million Crypto Liquidation Wave</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Bitcoin symbol is seen on Bitcoin ATM kiosk in the city center of Krakow, Poland on July 26th, 2024. (Photo by Beata Zawrzel/NurPhoto via Getty Images)

Semler Scientific Acquires Bitcoin Worth Over $20 Million, Total Holdings Cross 5,000 BTC

The company also reported a BTC Yield of 31.3% year-to-date return through July 23. 

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Semler Scientific, Inc. (NASDAQ: SMLR) and Encourages Long-Term Shareholders to Contact the Firm

Kaskela Law LLC announces that it is investigating Semler Scientific, Inc. (Semler) (NASDAQ: SMLR) on behalf of the companys shareholders. Click here for additional information...

Semler Scientific Reports Fourth Quarter and Full Year 2024 Financial Results with a BTC Yield of 107% since July 1, 2024; Now holds 3,192 BTC

Semler Scientific Reports Fourth Quarter and Full Year 2024 Financial Results with a BTC Yield of 107% since July 1, 2024; Now holds 3,192 BTC Semler Scientific Reports Fourth Quarter and Full Year...

Semler Scientific Announces Updated BTC Activity; Monetizes Minority Investment to Purchase BTC; Purchased Additional 871 BTC; Now Holds 3,192 BTC; YTD BTC Yield of 152.2% Since July 1, 2024

Semler Scientific Announces Updated BTC Activity; Monetizes Minority Investment to Purchase BTC; Purchased Additional 871 BTC; Now Holds 3,192 BTC; YTD BTC Yield of 152.2% Since July 1, 2024 Semler...

Shares of Semler Scientific Inc. (SMLR) dropped more than 11% in early trading on Friday after the&nbsp;healthcare company announced it had increased the size of its convertible senior note offering to $85 million, up from the initially planned $75 million.Meanwhile, other crypto-linked stocks like Genius Group Ltd. (6.7%), MARA Holdings Inc. (1.45%), Riot Platforms Inc. (6.2%) are others were in the green after President Donald Trump issued an executive order to create a cryptocurrency working group tasked with proposing new digital asset regulations as well as explore the creation of a “national digital asset stockpile.”Semler stated it would raise the funds through a private offering of convertible senior notes set to mature in 2030, with some of the proceeds going toward corporate activities, including buying more Bitcoin.The company also released its fourth quarter 2024 earnings results showing that its Bitcoin holdings have hit an unrealized gain of $28.9 million.&nbsp;Semler last bought 237 BTC on Jan. 13, bringing its total holdings to 2,321 BTC valued at around $241 million at the cryptocurrency’s current price of approximately $105,000.“We are excited to continue executing on our Bitcoin treasury strategy,” Semler CEO Doug Murphy-Chutorian said in a statement.Semler initially pivoted to include Bitcoin in its treasury in May, amid a plethora of publicly listed corporations buying the crypto hoping to see gains similar to Michael Saylor owned MicroStrategy (MSTR), which outpaced even Bitcoin’s 125% surge in 2024.The preliminary financial results for the fourth quarter estimate revenue of between $12.1 million and $12.5 million and operating income ranging from $3.4 million to $3.7 million.On Stocktwits, retail sentiment was largely bullish, despite the stock price dip, as users applauded the company’s decision to add to its Bitcoin treasury.Investors on the platform lauded the decision to raise capital through convertible notes rather than an at-the-market (ATM) offering, a move that avoids shareholder dilution.<stembedurl>https://stocktwits.com/SilentSniper/message/601245138</stembedurl><stembedurl>https://stocktwits.com/apatbeck79/message/601246038</stembedurl><stembedurl>https://stocktwits.com/GOLDSTANDARD25/message/601246175</stembedurl>Semler now ranks 13th among publicly traded companies with Bitcoin in their treasury.&nbsp;However, while Semler’s stock has gained 20% over the past year, its gains pale in comparison to Bitcoin, which more than doubled in value during the same period.&nbsp;Year-to-date, the stock remains flat.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/ericsson-q4-2024-earnings-miss-stock-drops-india-slowdown/chbQWyZRoQ">Ericsson Stock Plummets Pre-Market As India Slowdown Weighs On Q4 Profits: Retail Stays Extremely Bullish</a>

Bitcoin graphic illustration - stock photo

Semler Stock Plunges On Expanding Bitcoin Bet, But Retail Cheers Bond Plan

The dip occurred as other crypto-linked stocks were gaining after President Donald Trump’s executive order to create a cryptocurrency working group tasked with proposing new regulations as well as the possibility of a “national digital asset stockpile.”

Semler Scientific Announces Pricing of Upsized Offering of $85.0 Million Convertible Senior Notes

Semler Scientific Announces Pricing of Upsized Offering of $85.0 Million Convertible Senior Notes Semler Scientific Announces Pricing of Upsized Offering of $85.0 Million Convertible Senior Notes PR...

Semler Scientific Announces Select Preliminary Unaudited Fourth Quarter 2024 Financial Results and Significant Unrealized Gain from Change in Fair Value of Bitcoin Holdings

Semler Scientific Announces Select Preliminary Unaudited Fourth Quarter 2024 Financial Results and Significant Unrealized Gain from Change in Fair Value of Bitcoin Holdings Semler Scientific...

Semler Scientific Announces Proposed Private Offering of $75.0 Million of Convertible Senior Notes

Semler Scientific Announces Proposed Private Offering of $75.0 Million of Convertible Senior Notes Semler Scientific Announces Proposed Private Offering of $75.0 Million of Convertible Senior Notes...

Semler Scientific Announces Updated BTC and ATM Activity; Purchased Additional 237 BTC; Now Holds 2,321 BTC; BTC Yield of 99.3%

Semler Scientific Announces Updated BTC and ATM Activity; Purchased Additional 237 BTC; Now Holds 2,321 BTC; BTC Yield of 99.3% Semler Scientific Announces Updated BTC and ATM Activity; Purchased...

Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluates its customers’ patients for chronic disease, including heart attacks and strokes, using its QuantaFlo product as well as other tests. The company was founded by Herbert J. Semler, Guinasso Cindy and Shirley L. Semler on August 9, 2007 and is headquartered in Campbell, CA.

Semler Scientific Inc

Will Costco Wholesale ($COST) beat its quarterly EPS estimate? 
 
*Powered by Polymarket

Stocktwits

Costco Wholesale Corp

) beat its quarterly EPS estimate? 
 
*Powered by Polymarket

SMLR
Semler Scientific Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SMLR News

SMLR Semler Scientific Inc